Rheomuco CE marking funding

Rheonova is supported by the Auvergne Rhône-Alpes region to ensure compliance with the new European regulation for CE marking of our medical device Rheomuco and the associated quality management system.

The region, in collaboration with the Agency, Lyonbiopole and SNITEM (Syndicat National de L’industrie des Technologies Médicales) fund 50% of expenses through the SME TechMed support for medical marking 2020 strting October 2020 for a period of 1 year. For this purpose,Rheonova continue its parternership with Surgiqual Institute http://www.surgiqual-institute.com/2263-surgiqual-institute-partenaire-logiciel-et-reglementaire-de-rheonova/